Dermata Therapeutics, Inc.
DRMA
$1.29
$0.1210.26%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 12.29% | 9.35% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 1.37% | 7.93% | |||
| Operating Income | -1.37% | -7.93% | |||
| Income Before Tax | 0.76% | -10.04% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 0.76% | -10.04% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 0.76% | -10.04% | |||
| EBIT | -1.37% | -7.93% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 70.92% | 0.11% | |||
| Normalized Basic EPS | 70.92% | 0.11% | |||
| EPS Diluted | 70.85% | 0.11% | |||
| Normalized Diluted EPS | 70.92% | 0.11% | |||
| Average Basic Shares Outstanding | 241.28% | 10.15% | |||
| Average Diluted Shares Outstanding | 241.28% | 10.15% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||